Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00792727 · ClinicalTrials.gov registry record · Phase 3

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

A Phase 3 study, sponsored by Hisamitsu Pharmaceutical Co..

Completed
Registry status
Phase 3
Development phase
380
Enrollment target

NCT00792727: Completed Phase 3 study, sponsored by Hisamitsu Pharmaceutical Co..

NCT00792727 is a Phase 3 study that has completed, run by Hisamitsu Pharmaceutical Co.. The registered enrollment target is 380 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00792727, a Phase 3 study, has completed, sponsored by Hisamitsu Pharmaceutical Co..

COMPLETED
Registry status
Phase 3
Development phase
380 participants
Enrollment target

Study Summary

Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.

Interventions

  • OTHER Placebo Patch
  • DRUG ketoprofen Patch

Trial Details

FieldValue
Enrollment Target 380 participants
Start Date 2007-09
Est. Completion 2008-05
Phase Phase 3
Hisamitsu Pharmaceutical Co.

7 total trials

What the finished NCT00792727 record still lists

NCT00792727 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (51% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.

NCT00792727 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00792727 about?

NCT00792727 is a clinical study titled "HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain". Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.

What is the current status of trial NCT00792727?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 380 participants. The study started on 2007-09. Estimated completion is 2008-05.

What interventions are being tested in trial NCT00792727?

The interventions under investigation include: Placebo Patch (OTHER), ketoprofen Patch (DRUG).

Who is sponsoring clinical trial NCT00792727?

This trial is sponsored by Hisamitsu Pharmaceutical Co., which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00792727's enrollment target sits among peer trials

380 983rd of 2000 higher than 1,014 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04560673 · 380 participants · Phase 2

    Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

  • NCT04777357 · 380 participants · Phase 3

    A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

  • NCT04821154 · 380 participants

    Persona Revision Knee System Outcomes

  • NCT05102019 · 380 participants · NA

    Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00792727, the US trial registry maintained by the National Library of Medicine. NCT00792727 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.